English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
ENT and Allergy Associates
Patient Daily
| Jul 13, 2026
ENT & Allergy Associates announces Sydney C. Butts, MD, to join Brooklyn office in September
Patient Daily
| Jul 6, 2026
ENT & Allergy Associates of Pennsylvania adds Dr. Paul C. Frake to expand ENT services
Patient Daily
| Jun 9, 2026
ENT & Allergy Associates and Hümi select J.P. Morgan as primary bank and lender
Patient Daily
| Feb 11, 2026
ENT & Allergy Associates adds Dr. Sandra Ho to Manhasset office
Patient Daily
| Jan 15, 2026
ENT & Allergy Associates adds otolaryngologist Christopher V. Lisi to West Nyack office
Patient Daily
| Jan 14, 2026
Otolaryngologist Evan Sarti to join ENTA’s new Morristown location in February 2026
Patient Daily
| Dec 8, 2025
ENT & Allergy Associates of Texas adds fellowship-trained rhinologist Karen Bednarski to Katy office
Patient Daily
| Dec 3, 2025
ENT & Allergy Associates partners with Houston group for first Texas expansion
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Regulatory
L. R. Alvarez
| Jul 30, 2026
TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+
Regulatory
J. R. Bair
| Jul 28, 2026
Employers for Hospital Accountability: 'Participating hospitals are stockpiling far more assets than similar non-340B hospitals'
+
Pharmaceuticals
Patient Daily
| Jul 30, 2026
Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak